You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed Osteosarcoma

Showing 1 - 25 of 5,613
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory

Active, not recruiting
Has Results
  • Metastatic Ewing Sarcoma
  • +9 more
  • Cabozantinib S-malate
  • Laboratory Biomarker Analysis
  • Bordeaux, France
  • +10 more
Nov 26, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Osteosarcoma, Sarcoma Trial (HS-20093)

Not yet recruiting
  • Osteosarcoma
  • Sarcoma
  • (no location specified)
Apr 26, 2023

Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)

Not yet recruiting
  • Osteogenic Sarcoma Recurrent
  • Hackensack, New Jersey
  • +1 more
Feb 3, 2023

Ewing Sarcoma, Osteosarcoma Trial in San Francisco, Aurora, Philadelphia (Cabozantinib)

Recruiting
  • Ewing Sarcoma
  • Osteosarcoma
  • San Francisco, California
  • +4 more
Nov 24, 2023

Osteosarcoma in Children Trial (Dinutuximab beta)

Not yet recruiting
  • Osteosarcoma in Children
  • Dinutuximab beta
  • (no location specified)
Sep 23, 2022

Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma

Completed
  • Osteosarcoma Recurrent
  • Osteosarcoma Metastatic
  • observation
  • Milan, Milano, Italy
  • +7 more
Nov 24, 2021

Osteosarcoma Trial in China, Korea, Republic of (Sulfatinib, Etoposide, Isophosphamide)

Not yet recruiting
  • Osteosarcoma
  • Beijing, Beijing, China
  • +4 more
Oct 19, 2022

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,

Recruiting
  • Relapsed Ewing Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 27, 2021

Osteosarcoma Trial (Vactosertib)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Oct 18, 2022

Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

Recruiting
  • Osteosarcoma
  • +3 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Xi'an, Shaanxi, China
    Xi'an Honghui Hospital
May 8, 2023

High Dose Isofosfamide Through Elastomer

Active, not recruiting
  • Osteosarcoma Recurrent
  • Observational study
  • Bologna, Italy
  • +4 more
Aug 11, 2022

Effect of Drug, Drug, Toxicity Trial in Beijing (Apatinib+IE, IE)

Recruiting
  • Effect of Drug
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Mar 12, 2022

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)

Terminated
  • Neuroblastoma
  • +2 more
  • Humanized 3F8 Bispecific Antibody
  • Blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 11, 2022

Relapsed Neuroblastoma, Refractory Neuroblastoma, Relapsed Osteosarcoma Trial in Houston (C7R-GD2.CART cells, Cyclophosphamide,

Recruiting
  • Relapsed Neuroblastoma
  • +6 more
  • C7R-GD2.CART cells
  • +2 more
  • Houston, Texas
  • +1 more
Nov 12, 2021

Osteosarcoma Trial in France, United States (ZN-c3, Gemcitabine)

Recruiting
  • Osteosarcoma
  • Los Angeles, California
  • +15 more
Aug 9, 2022

Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

Recruiting
  • Recurrent Neuroblastoma
  • +3 more
  • Palo Alto, California
  • +3 more
Jan 25, 2023

Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

Recruiting
  • Osteosarcoma
  • +9 more
  • Cryoablation Therapy
  • +2 more
  • Washington, District of Columbia
    Children's National Hospital
Mar 21, 2022

Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

Recruiting
  • Neuroblastoma
  • +5 more
  • GD2-CART01
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

Effect of Drug, Toxicity, Drug Trial in Beijing (apatinib)

Recruiting
  • Effect of Drug
  • Toxicity, Drug
  • Beijing, Beijing, China
  • +1 more
Jul 12, 2021

Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

Active, not recruiting
  • Relapsed Pediatric Solid Tumors
  • +9 more
  • Magnetic Resonance High Intensity Focused Ultrasound
  • Washington, District of Columbia
  • +1 more
Jan 21, 2022

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021